Singapore, Aug. 5 -- The Asian Development Bank (ADB) and the Drugs for Neglected Diseases initiative (DNDi) have signed a Memorandum of Understanding (MoU) to formalise a non-exclusive framework of cooperation to promote programmes and projects in the field of healthcare across Asia and the Pacific (APAC).

The collaboration aims to jointly focus on shared strategic and operational priorities, including neglected diseases with increasing prevalence due to climate change such as leishmaniasis and dengue; pandemic preparedness; and technology transfer for local manufacturing.

The MoU also focuses on enhancing gender-responsive research and development and developing therapeutics for pediatric populations living with neglected diseases. It...